Cognitive Therapy Combined with Drug Treatment in Patients with Alzheimer’s Disease: A Neuropsychological and Positron Emission Tomography Investigation, a Pilot Study
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 나해리 | - |
dc.contributor.author | 김상윤 | - |
dc.contributor.author | Yu Kyeong Kim | - |
dc.contributor.author | 박문호 | - |
dc.contributor.author | Sung Tae Cho | - |
dc.contributor.author | Woo Jung Kim | - |
dc.date.accessioned | 2021-09-04T22:47:09Z | - |
dc.date.available | 2021-09-04T22:47:09Z | - |
dc.date.created | 2021-06-17 | - |
dc.date.issued | 2015 | - |
dc.identifier.issn | 1738-1495 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/95552 | - |
dc.description.abstract | Background Cognitive therapy may have therapeutic benefit in patients with early Alzheimer’s disease (AD). Case ReportThis was a 12-week, single-blind pilot study of 4 patients with AD. The cognitive therapy included exercises for orientation to time and place; memory training, including face-name association, object recall training, and spaced retrieval; visuo-motor organization using software; similarity and ruled based categorization; and behavior modification and sequencing (e.g., making change, paying bills). The regional cerebral metabolic abnormalities and the effects of treatment on cortical metabolic responses were evaluated using 18F-2-fluoro-2-deoxy-D-glucose positron emission tomography (PET). After 12 weeks, the participants showed slight improvement in some neuropsychological measures, and three of them showed increased regional cortical metabolism on brain PET studies. ConclusionsCognitive therapy may stabilize or improve cognitive and functional performance of patients with early AD and increase regional cortical metabolism of the patients’ brain. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | 대한치매학회 | - |
dc.title | Cognitive Therapy Combined with Drug Treatment in Patients with Alzheimer’s Disease: A Neuropsychological and Positron Emission Tomography Investigation, a Pilot Study | - |
dc.title.alternative | Cognitive Therapy Combined with Drug Treatment in Patients with Alzheimer’s Disease: A Neuropsychological and Positron Emission Tomography Investigation, a Pilot Study | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | 박문호 | - |
dc.identifier.doi | 10.12779/dnd.2015.14.2.76 | - |
dc.identifier.bibliographicCitation | Dementia and Neurocognitive Disorders(대한치매학회지), v.14, no.2, pp.76 - 82 | - |
dc.relation.isPartOf | Dementia and Neurocognitive Disorders(대한치매학회지) | - |
dc.citation.title | Dementia and Neurocognitive Disorders(대한치매학회지) | - |
dc.citation.volume | 14 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 76 | - |
dc.citation.endPage | 82 | - |
dc.type.rims | ART | - |
dc.identifier.kciid | ART002012867 | - |
dc.description.journalClass | 2 | - |
dc.description.journalRegisteredClass | kci | - |
dc.subject.keywordAuthor | cognitive therapy | - |
dc.subject.keywordAuthor | Alzheimer’s disease | - |
dc.subject.keywordAuthor | 18F-2-fluoro-2-deoxy-D-glucose positron emission tomography. | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.